newsfilter
← Latest News
PR Newswire·

BioLife Solutions Announces the Sale of its evo Cold Chain Logistics Subsidiary

  • BioLife Solutions announced the sale of its wholly owned subsidiary SAVSU Cleo Technologies to Peli BioThermal for $25.5 million in cash, subject to adjustments.
  • The divestiture aims to streamline BioLife's product portfolio & operations while redirecting resources toward high-margin recurring revenue.
  • CEO Roderick de Greef stated that the sale recognizes the value of SAVSU's evo technology within the cold chain logistics sector.
  • BioLife remains a leading developer of cell processing tools & services for the cell & gene therapy market.